SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-16-000141
Filing Date
2016-08-12
Accepted
2016-08-12 08:17:25
Documents
3
Period of Report
2016-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ebioform8kq22016earnings.htm 8-K 35459
2 EXHIBIT 99.1 q22016prvfinal.htm EX-99.1 133687
3 ebiologoa07.jpg GRAPHIC 89522
  Complete submission text file 0001485003-16-000141.txt   293438
Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 161826286
SIC: 2834 Pharmaceutical Preparations